Canna Law Blog

AUGUST 28, 2022

Before diving into this latest development, I should mention that historically, cannabis is treated differently from federal agency to federal agency. And when it comes to cannabis and public policy, the FTC is much closer to the NLRB than, let’s say, the IRS. CBD consumer safety enforcement.

Safety 78

Safety CBD Research and Development Business 78

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Opportunities for Federal Support of Psychedelics Research. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . This new program is being funded by private investors, including Matt Wullenweg, developer of WordPress, and philanthropist Tim Ferriss. Professor of Law at Harvard Law School.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. Allison Feduccia, PhD is a neuropharmacologist, psychedelic researcher, and a builder of virtual and in-person communities. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS.

Safety 52

Safety Medicine Therapy Research and Development 52

Veriheal

FEBRUARY 14, 2024

The board will work on projects like designing the training program for psychedelic facilitators, tracking psychedelic policy development, studying ongoing science related to psilocybin, and making recommendations to lawmakers regarding the bill. Arizona is making progressive steps forward when it comes to psychedelic research.

Therapy 62

Therapy Legalization Research and Development Treatment 62

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

SEPTEMBER 22, 2021

Despite this, the Home Office “fails to act, perpetuating what can be considered the worst research blackout in scientific history,” according to the Conservative Drug Policy Reform Group (CDPRG), of which Mr Blunt is chairman. The first part of their review was published in July and the second part of the work is now underway.

Research and Development 52

Research and Development Clinical Trials Treatment History 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JUNE 25, 2021

Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines. David Nutt, has joined its executive team as Chief Research Officer. Toronto, Ontario–(Newsfile Corp. June 24, 2021) – Awakn Life Sciences Corp.

Research and Development 66

Research and Development Therapy Medicine Pets 66

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

Project CBD

JULY 28, 2023

From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. with unknown pharmacological and safety profiles.” End cannabis prohibition, the market for these products will go away and these compounds will be relegated to research labs, where they belong, not the marketplace.

THC 212

THC Cannabinoids Hemp Research and Development 212

Veriheal

OCTOBER 20, 2022

According to UC Berkeley’s Department of Environmental Science Policy and Management researchers, California’s cannabis crops are threatened by wildfires more than any other crop. . The research was featured in the journal Ecosphere. . California’s wildfires came first on the high-risk list, followed by grapes (8.8%

Agriculture 105

Agriculture Research and Development Safety Cultivation 105

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

OCTOBER 5, 2021

The National Safety Council (NSC), America’s leading nonprofit safety advocate, released results of a survey conducted as part of an ongoing effort to assess the risks of cannabis in the workplace and the results are clear: employers must do more to educate and protect their workers. ET : Cannabis and Safety. 11 , 10:30 a.m.

Safety 52

Safety Research and Development Policy Education 52

Cannabis Law Report

AUGUST 22, 2021

But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience. Interesting piece from Lucid news. Read the full report at .

Research and Development 105

Research and Development Decriminalization Education Safety 105

PrestoDoctor

JANUARY 30, 2024

Connection between cannabis use and psychosis The connection between cannabis use and psychosis has been a topic of much research and debate. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms. These interactions may contribute to the development of cannabis-induced psychosis.

Research and Development 52

Research and Development Treatment Conditions Education 52

Cannabis Law Report

SEPTEMBER 7, 2022

a leading global cannabis and consumer packaged goods company, announced that the company has initiated a policy roundtable with German regulators on adult-use cannabis legalization in Germany. Kristine Lütke, Member of the Bundestag (FDP), Drug Policy Spokesperson. BERLIN, Sept. 6, 2022 – PRES RELEASE – Tilray Brands Inc. ,

Legislation 64

Legislation Supply Chain Research and Development Safety 64

The Cannigma

JUNE 2, 2023

The possession, use, and trafficking of cannabis are illegal, and the country maintains a zero-tolerance policy towards drugs. The government remains steadfast in its commitment to maintaining strict drug laws to ensure public safety. Singapore has shown no indication of considering the legalization or decriminalization of cannabis.

Law 52

Law Research and Development Consumption Therapy 52

Cannabis Law Report

AUGUST 11, 2021

HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. With a strong focus on research and development, HempFusion has an additional 30 products under development.

Research and Development 105

Research and Development Tincture Food Hemp 105

Cannabis Law Report

FEBRUARY 13, 2022

The Program Specialist 2 (Cannabis) positions will perform applicant and licensee inspection of physical facilities, adherence to program regulations, development of guidance documents and statement of findings and other duties ensuring licensees are complying with public health and safety best practices. of the NYS Civil Service Law.

Programs 52

Programs Research and Development Seed-To-Sale Compliance 52

Cannabis Law Report

MARCH 17, 2022

Interested in public service, policy, and continuing to build a more inclusive cannabis industry in Massachusetts? Request for Responses (RFR): External Research Review. There are opportunities available now to work or contract with the Cannabis Control Commission (Commission). Please share this information with your networks.

Compliance 52

Compliance Compliance Research and Development Data 52

Cannabis Law Report

MARCH 10, 2022

Within 90 days of enactment of this Act, the FDA shall issue a policy of enforcement discretion with regard to certain products containing CBD meeting the definition of hemp as defined by section 297A of the Agricultural Marketing Act of 1964 (7 U.S.C.

Hemp 52

Hemp Research and Development Advocacy CBD 52

Cannabis Law Report

SEPTEMBER 23, 2022

Going forward, MAPS will focus on advocating for psychedelic policy reform to include state funding for public education, harm reduction, and unarmed crisis response services. On the heels of the update about SB 519 was news of Governor Gavin Newsom vetoing another proposed piece of drug policy legislation sponsored by Senator Wiener.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

Cannabis Law Report

JULY 6, 2021

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ?9-tetrahydrocannabinol for beta testing.

Research and Development 105

Research and Development THC Safety Events 105

Cannabis Law Report

FEBRUARY 28, 2022

The Board will also develop a long-term strategic plan for ensuring that psilocybin services will become and remain a safe, accessible and affordable therapeutic option for all persons 21 years of age and older in this state for whom psilocybin may be appropriate and monitor and study federal laws, regulations and policies regarding psilocybin.

Research and Development 105

Research and Development Safety Policy Conditions 105

SpeedWeed

JULY 28, 2021

PSI Labs has not yet conducted extensive research into what type of contaminants can be found in delta-8 products due to costs; however, the laboratory has brought in off-the-shelf delta-8 products from places like vape shops and gas stations for testing, and they’ve discovered discrepancies in the products. THC limit,” he says.

Research and Development 52

Research and Development Packaging Hemp Cannabinoids 52

MMJ Recs

MARCH 14, 2024

Moreover, dispensaries must implement robust security measures to prevent theft and ensure patient safety. By adhering to rigorous testing requirements and standards, West Virginia’s medical marijuana program prioritizes patient safety and promotes the availability of high-quality, effective medical marijuana products.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

MAY 26, 2022

The OPEN Foundation invites you to the Interdisciplinary Conference on Psychedelic Research this September, featuring the world’s best experts on psychedelic science and therapy. Research participant perspectives are featured prominently, and experts will discuss issues around ethics, investment, and the hype surrounding psychedelics.

Research and Development 52

Research and Development Therapy Policy Media 52

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JULY 20, 2021

Elliott was the Governor’s Senior Advisor on Cannabis at the Governor’s Office of Business and Economic Development. She held multiple positions in the Office of San Francisco Mayor Gavin Newsom from 2009 to 2010, including Budget Office Policy Assistant, Director of Scheduling and Deputy Board Liaison. Biographies.

Research and Development 105

Research and Development Compliance Compliance Food 105

Veriheal

OCTOBER 7, 2022

That is until the Occupational Safety and Health Administration (OSHA) report on the incident hit the web earlier this week. According to OSHA, Trulieve was partly to blame for the incident, as it failed to provide its employees with proper workplace safety hazards and training. Despite this, the news initially flew under the radar.

Blood Pressure 97

Blood Pressure Research and Development Safety Cannabis 97

MMJ Recs

MARCH 23, 2024

Additionally, legalization may lead to increased research opportunities into the therapeutic properties of cannabis, potentially uncovering new medical uses and treatment modalities. However, there are worries about increased cannabis use, particularly among young people, and potential impacts on mental health and road safety.

Legalization 52

Legalization Access Programs Education 52

SpeedWeed

FEBRUARY 19, 2021

Members share information, “develop more uniformity across state frameworks” and “assist federal, state and local jurisdictions that have approved or are weighing the legalization of cannabis.”. 18 missive to Congress, the CANNRA outlined its policy priorities, including: Reinstituting the Cole Memorandum.

Research and Development 52

Research and Development Marijuana Banking Policy 52

Cannabis Law Report

JANUARY 10, 2020

Medical Cannabis Network is delighted to begin working with the board and are excited to share with our readers dynamic new developments in the world of medical cannabis. Research Manager at Drug Science and Honorary Fellow at Imperial College London. Meet the board. Anne Schlag. Deepak Anand.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

The Cannigma

JANUARY 21, 2021

It is currently being researched as a treatment for a long list of conditions, such as dementia, PTSD, ADHD, Huntington’s disease, ALS, Parkinson’s disease, multiple sclerosis, diabetes, colitis, and of course, pain. And unlike THC and CBD, there’s practically no scientific information about the safety or dosing of CBG-dominant products.

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

Cannabis Law Report

MAY 18, 2022

The majority of conversations at the Medical Psychedelics House of Davos will focus on regulatory approval for these compounds, their therapeutic potential, policy, safety and efficacy, biocultural preservation, drug development pipelines, and patient access.

Research and Development 52

Research and Development Therapy Treatment Policy 52